MAGENTA CLINICAL TRIAL
Live / Applied — First extension granted (statement of use) (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 10 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98895084
- Mark type
- Design + words
- Filed
- 10 Dec 2024
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Elizabeth P. West
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of CNS (central nervous system) diseases
Owner
- IGC Pharma IP, LLC, Potomac, MD, US
- IGC Pharma IP, LLC, Potomac, MD, US
Prosecution history
- 28 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2026 — SOU EXTENSION 1 GRANTED
- 27 Mar 2026 — SOU EXTENSION 1 FILED
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jun 2025 — NON-FINAL ACTION E-MAILED
- 11 Jun 2025 — NON-FINAL ACTION WRITTEN